Development of antiinfliximab antibodies and relationship to clinical response in patients with rheumatoid arthritis-Reference-Cited by-同舟云学术

Development of antiinfliximab antibodies and relationship to clinical response in patients with rheumatoid arthritis

Published:2006 Issue:3 Volume:54 Page:711-715
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis Rheum

Author:

Wolbink Gerrit Jan,Vis Marijn,Lems Willem,Voskuyl Alexandre E.,De Groot Els,Nurmohamed Michael T.,Stapel Steven,Tak Paul P.,Aarden Lucien,Dijkmans Ben

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Reference12 articles.

1. Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor ? monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis

2. Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate

3. The relationship of serum infliximab concentrations to clinical improvement in rheumatoid arthritis: Results from ATTRACT, a multicenter, randomized, double-blind, placebo-controlled trial

4. American college of rheumatology preliminary definition of improvement in rheumatoid arthritis

5. Relationship between serum trough infliximab levels, pretreatment C reactive protein levels, and clinical response to infliximab treatment in patients with rheumatoid arthritis

Cited by 408 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimizing withdrawal strategies for anti-TNF-α therapies in rheumatoid arthritis;Expert Opinion on Biological Therapy;2024-07-25

2. Smoking and rheumatoid arthritis;Russian Family Doctor;2024-07-15

3. Performance of Eight Infliximab Population Pharmacokinetic Models in a Cohort of Dutch Children with Inflammatory Bowel Disease;Clinical Pharmacokinetics;2024-03-15

4. Early infliximab trough levels in paediatric IBD patients predict sustained remission;Therapeutic Advances in Gastroenterology;2023-12-30

5. Effectiveness of strategies to suppress antibodies to infliximab in pediatric inflammatory bowel disease;Journal of Pediatric Gastroenterology and Nutrition;2023-12-05